Kung CP, Cottrell KA, Ryu S, Bramel ER, et al. Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer. Oncogene 2021 Feb 9. pii: 10.1038/s41388-021-01669.
PMID: 33564075